These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7769581)

  • 1. A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus.
    Ogasawara M; Aoki K; Hayashi Y
    J Reprod Immunol; 1995 Feb; 28(2):159-64. PubMed ID: 7769581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera.
    Katano K; Aoki K; Ogasawara M; Sasa H; Hayashi Y; Kawamura M; Yagami Y
    Lupus; 1995 Aug; 4(4):304-8. PubMed ID: 8528228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death.
    Qamar T; Levy RA; Sammaritano L; Gharavi AE; Lockshin MD
    Arthritis Rheum; 1990 Apr; 33(4):501-4. PubMed ID: 2109614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies.
    Nakamura Y; Yoshida K; Itoh S; Kanai Y; Tsuda H; Hashimoto H; Mitsuhashi N; Kuwabara Y
    Am J Reprod Immunol; 1999 May; 41(5):307-11. PubMed ID: 10378025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM; Porter TF; Branch DW; Laskin CA; Merrill JT; Guerra MM; Lockshin MD; Buyon JP; Petri M; Sammaritano LR; Stephenson MD; Kim MY; Salmon JE
    Arthritis Rheumatol; 2016 Aug; 68(8):1964-9. PubMed ID: 26990620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent abortion and moderate or strong antiphospholipid antibody production.
    Ogasawara M; Sasa H; Katano K; Aoyama T; Aoki K; Suzumori K
    Int J Gynaecol Obstet; 1998 Aug; 62(2):183-8. PubMed ID: 9749890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
    Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
    Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies.
    Ogishima D; Matsumoto T; Nakamura Y; Yoshida K; Kuwabara Y
    Pathol Int; 2000 Mar; 50(3):224-9. PubMed ID: 10792786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
    Al Arfaj AS; Khalil N
    Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological evolution in women with positive antiphospholipid antibodies.
    Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
    Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aspirin and prednisone treatment of pregnancy loss caused by lupus anticoagulants.
    Harger JH; Laifer SA; Bontempo FA; Senich LA; Church C
    J Perinatol; 1995; 15(6):463-9. PubMed ID: 8648455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
    Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP
    Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.